Aurora Cannabis (ACB) Payables (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Payables data on file, last reported at $93.1 million in Q4 2025.

• Payables for Q4 2025 came in at $93.1 million, down 13.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $93.1 million (down 13.8% YoY), and the FY2025 annual result was $79.3 million, down 21.26% from the prior year.
• Payables grew to $93.1 million in Q4 2025 per ACB's latest filing, from $79.3 million in the prior quarter.
• Over five years, Payables peaked at $108.0 million in Q4 2024 and troughed at $41.9 million in Q4 2021.
• A 5-year average of $73.7 million and a median of $76.6 million in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2021 and 2022: Payables sank 72.56% in 2021, then soared 136.33% in 2022.
• A 5-year view of Payables shows it stood at $41.9 million in 2021, then surged by 97.67% to $82.8 million in 2022, then advanced by 13.15% to $93.7 million in 2023, then increased by 15.25% to $108.0 million in 2024, then dropped by 13.8% to $93.1 million in 2025.
• Business Quant data shows ACB's Payables at $93.1 million in Q4 2025, $79.3 million in Q3 2025, and $101.9 million in Q2 2025.